Inactive Instrument

Vitalibis Inc Share Price Other OTC

Vitalibis, Inc. engages in the development, sale, and distribution of hemp oil-based products that contain naturally occurring cannabinoids, such as cannabidiol (CBD). The Company markets consumer products containing full spectrum phytocannabinoid-rich hemp oil under the Vitalibis brand across various market sectors, including wellness and personal care. It distributes approximately eight products under its brand. It also sells water-soluble, full spectrum phytocannabinoid-rich hemp powder with naturally occurring CBD to various customers in the United States who use these products for resale. The Company has also started offering non-exclusive leases of its technology back-end through a Software as a Service (SaaS) platform. This platform, branded as Vitalibis, provides hosting, technical services, and a comprehensive e-commerce affiliate application as part of its SaaS offerings.

Employees

Sector

Pharmaceuticals

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	430K 372K 347K 319K 599K 40.91M 609K 4.07M 1.6M 20.5M 1.61M 1.58M 67.78M	P/E 2018	-21.3x	P/E 2019	-0.95x
Enterprise Value	1.53M 1.32M 1.23M 1.13M 2.13M 145M 2.16M 14.46M 5.68M 72.8M 5.73M 5.61M 241M	EV / Sales 2018	949,389,161x	EV / Sales 2019	25,985,979x
Free-Float	54.42%	Yield 2018 *	-	Yield 2019	-

14/10/25	Zhejiang Bayi Electronics Technology Co., Ltd. entered into a non-binding letter of intent to acquire Vitalibis, Inc..	CI
02/09/21	Vitalibis, Inc. Bankruptcy Case Dismissed	CI
02/08/21	Motion for Case Dismissal Filed for Vitalibis, Inc.	CI
19/11/20	Disclosure Statement Conditionally Approved for Vitalibis, Inc.	CI
18/11/20	Reorganization Plan and Disclosure Statement Filed by Vitalibis, Inc.	CI
17/11/20	Vitalibis, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	CI
14/08/20	Vitalibis, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	CI
15/06/20	Vitalibis, Inc. Filed for Bankruptcy	CI
15/05/20	Vitalibis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	CI
01/04/20	Vitalibis, Inc. Alliance with Bruce Lee Beverage by Offering Actual Being™ Focus Adaptogen + Superfood Herbal Supplement	CI
13/03/20	Vitalibis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	CI
12/03/20	Vitalibis, Inc. Auditor Raises 'Going Concern' Doubt	CI
28/01/20	Vitalibis, Inc. Launches CBD+ Skincare Product Line	CI

10/09/21	VITALIBIS, INC. : Other Events (form 8-K)	AQ
17/11/20	VITALIBIS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
14/08/20	VITALIBIS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
16/06/20	VITALIBIS, INC. : Bankruptcy or Receivership (form 8-K)	AQ
03/06/20	VITALIBIS, INC. : Other Events (form 8-K)	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VITALIBIS INC	-.--%	-.--%	-	-	230K
ELI LILLY AND COMPANY	-0.52%	+3.21%	+89.52%	+127.32%	1,057B
JOHNSON & JOHNSON	+0.88%	+1.13%	+49.56%	+49.69%	625B
ABBVIE INC.	+0.89%	-1.95%	+24.23%	+64.44%	435B
ROCHE HOLDING AG	+0.71%	+3.87%	+49.07%	+37.85%	363B
NOVARTIS AG	+0.64%	-0.49%	+33.94%	+40.01%	296B
ASTRAZENECA PLC	+0.39%	-5.83%	+8.92%	+7.85%	249B
AMGEN INC.	+1.51%	+6.69%	+42.58%	+57.57%	222B
NOVO NORDISK A/S	+3.92%	-0.46%	-5.56%	-52.32%	209B
GILEAD SCIENCES, INC.	+1.80%	+2.30%	+11.56%	+66.35%	165B
Average	+1.02%	+0.87%	+33.76%	+44.31%	402.31B
Weighted average by Cap.	+0.66%	+1.22%	+48.72%	+64.63%

	2018	2019
Net sales	0.05 0.04 0.04 0.04 0.07 4.89 0.07 0.49 0.19 2.45 0.19 0.19 8.1	0.3 0.26 0.24 0.22 0.42 28.86 0.43 2.87 1.13 14.46 1.14 1.11 47.81
Net income	-2.23M -1.93M -1.8M -1.65M -3.11M -212M -3.16M -21.12M -8.29M -106M -8.37M -8.19M -351M	-6.85M -5.92M -5.53M -5.07M -9.54M -652M -9.69M -64.88M -25.47M -327M -25.71M -25.15M -1.08B
Net Debt	-161K -139K -130K -119K -224K -15.28M -227K -1.52M -597K -7.66M -603K -590K -25.33M	1.1M 948K 886K 812K 1.53M 104M 1.55M 10.39M 4.08M 52.3M 4.12M 4.03M 173M

Vitalibis Inc Share Price Other OTC

Stocks

Pharmaceuticals

Valuation: Vitalibis Inc

Latest news : Vitalibis Inc

Press Releases: Vitalibis Inc

Managers and Directors: Vitalibis Inc

Other Pharmaceuticals

Financials

Company Profile